Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuzi Chen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of General Medicine|May 14, 2025
A Clinical Risk Prediction Model for Depressive Disorders Based on Seven Machine Learning AlgorithmsWeifeng Jin, Shuzi Chen, Mengxia Wang, et al.
Frontiers in Medicine|January 21, 2026
A clinical prediction model for schizophrenia based on machine learning algorithmsWeifeng Jin, Shuzi Chen, Qiong Gao, et al.
Heliyon|December 19, 2024
Metabolic effects and clinical outcomes of olanzapine in schizophrenia: A systematic review and meta-analysisWeifeng Jin, Shuzi Chen, Dan Li, et al.
Neuropsychiatric Disease and Treatment|August 6, 2025
Advances and Challenges in Depression Marker ResearchWeifeng Jin, Shuzi Chen, Dan Li, et al.
Heliyon|July 8, 2024
UPLC-MS/MS determination of 71 neuropsychotropic drugs in human serumWeifeng Jin, Jianhua Wang, Shuzi Chen, et al.
Frontiers in Neuroscience|August 9, 2021
Research Progress on the Correlation Between Epigenetics and SchizophreniaQing Chen, Dan Li, Weifeng Jin, et al.
Nutrients|April 13, 2023
Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive DisorderPing Lin, Dan Li, Yun Shi, et al.
General Psychiatry|March 21, 2022
Consensus on potential biomarkers developed for use in clinical tests for schizophreniaPing Lin, Junyu Sun, Xiaoyan Lou, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of General Medicine|May 14, 2025
A Clinical Risk Prediction Model for Depressive Disorders Based on Seven Machine Learning AlgorithmsWeifeng Jin, Shuzi Chen, Mengxia Wang, et al.
Frontiers in Medicine|January 21, 2026
A clinical prediction model for schizophrenia based on machine learning algorithmsWeifeng Jin, Shuzi Chen, Qiong Gao, et al.
Heliyon|December 19, 2024
Metabolic effects and clinical outcomes of olanzapine in schizophrenia: A systematic review and meta-analysisWeifeng Jin, Shuzi Chen, Dan Li, et al.
Neuropsychiatric Disease and Treatment|August 6, 2025
Advances and Challenges in Depression Marker ResearchWeifeng Jin, Shuzi Chen, Dan Li, et al.
Heliyon|July 8, 2024
UPLC-MS/MS determination of 71 neuropsychotropic drugs in human serumWeifeng Jin, Jianhua Wang, Shuzi Chen, et al.
Frontiers in Neuroscience|August 9, 2021
Research Progress on the Correlation Between Epigenetics and SchizophreniaQing Chen, Dan Li, Weifeng Jin, et al.
Nutrients|April 13, 2023
Dysbiosis of the Gut Microbiota and Kynurenine (Kyn) Pathway Activity as Potential Biomarkers in Patients with Major Depressive DisorderPing Lin, Dan Li, Yun Shi, et al.
General Psychiatry|March 21, 2022
Consensus on potential biomarkers developed for use in clinical tests for schizophreniaPing Lin, Junyu Sun, Xiaoyan Lou, et al.
Pageof 1